Hot News of catalent1738774898-1738771685
Warning: Undefined variable $da in
/var/www/hoodb/trend.php on line
250
Quick search catalent on following websites.
catalent Keywords
Collect keywords that netizens have searched for catalent
1738774898-1738468854
Warning: filemtime(): stat failed for aCache/Gkeys/dk/catalent-2 in
/var/www/hoodb/function.php on line
339
1738774898-
More catalent news:
1738774899-1738468855
-
Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus - Reuters
-
Novo Holdings’ purchase of Catalent set to close after regulators’ green light - BioPharma Dive
-
Novo Holdings completes Catalent acquisition for $16.5bn - Pharmaceutical Technology
-
Backlash builds against Novo’s Catalent takeover - PharmaVoice
-
Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 Work - BioSpace
-
New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO - FiercePharma
-
Novo Holdings completes $16.5B acquisition of Catalent - Inside INdiana Business
-
Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidote - Endpoints News
-
Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent - Reuters
-
Catalent's Award-Winning Innovations and Community Engagement Initiatives - Pharmaceutical Technology
-
Novo-Catalent Deal Represents ‘Defining Moment’ for CDMO Sector - BioSpace
-
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close - FiercePharma
-
Catalent to support manufacturing for Galapagos’ GLPG5101 - Pharmaceutical Technology
-
Catalent misses Q1 revenue estimates ahead of $16.5 bln deal close with Novo Holdings - Reuters
-
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’ - BioSpace
-
Novo Holdings set to close $16.5B Catalent buy in 'coming days' after deal clears antitrust hurdles - FiercePharma
-
Catalent to sell New Jersey facility - Reuters.com
-
Novo Holdings’ acquisition of Catalent gains EC approval - Pharmaceutical Technology
-
Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena - FiercePharma
-
Roche comes out against allowing takeover of drug manufacturer Catalent - Reuters
-
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts - BioSpace
-
Catalent Misses Fiscal Q1 Revenue Expectations as Pressure Mounts on Novo Holdings’ $16.5B Buyout - BioSpace
-
Warren calls on FTC to scrutinize Novo Holdings' $16.5B Catalent buyout - FiercePharma
-
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility - Business Wire
-
Catalent reports upbeat Q4 results as it awaits FTC review of $16.5B sale to Novo - FiercePharma
-
EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6 - Reuters
-
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal - Reuters
-
Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook - BioProcess Insider
-
Novo Holdings set to win EU nod for $16.5 bln Catalent deal, source says - Reuters.com
-
What Novo’s takeover of Catalent could mean for Bloomington workers - Indiana Daily Student
-
Catalent beats revenue estimates ahead of deal close with Novo Holdings - Reuters.com
-
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal - FiercePharma
-
Don’t expect Novo-Catalent merger investigation to fizzle out under the new Trump administration - STAT
-
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers - FiercePharma
-
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition - BioSpace
-
JPM 2025: Thermo Fisher ‘very positive’ on sterile demand as Catalent takes capacity out of market - Pharmaceutical Technology
-
Italy Blocks Chinese AI Model DeepSeek Over Data Privacy Concerns - PYMNTS.com
-
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review - BioSpace
-
European regulators approve $16.5 billion deal for Novo Holdings to buy Catalent - STAT
-
Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval - Reuters
-
Catalent, Inc. Reports First Quarter Fiscal 2025 Results - BioSpace
-
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout - Reuters
-
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal - Reuters.com
-
We're reading about Novo Holdings-Catalent deal, Sanofi sanctions| STAT - STAT
-
Amid Novo Buy, Catalent Offloads New Jersey Facility to Ardena - BioSpace
-
Novo Holdings Completes Acquisition of Catalent - Contract Pharma
-
Catalent to sell New Jersey drug facility to Ardena - Manufacturing Dive
-
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say - Reuters
-
Amazon Expands Its Footprint in Healthcare, Taking on Walmart’s Role as a Key Provider - PYMNTS.com
-
Consumer groups ask FTC to block Novo Holdings-Catalent deal - Reuters
-
Pace Life Sciences Acquires Analytical Services Laboratory from Catalent - Contract Pharma
-
How Novo’s Acquisition Of Catalent Cleared European Regulators - News & Insights
-
FTC request may signal trouble for Novo/Catalent deal - PharmaVoice
-
Novo Holdings is set to close its $16.5 billion acquisition of Catalent after FTC declines to challenge the deal - STAT
-
Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany - Business Wire
-
Unions, Public Interest Groups Call on FTC to Challenge Novo Holdings-Catalent Acquisition - BioSpace
-
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings - Business Wire
-
Catalent tries to reassure customers about its deal with Novo Holdings - STAT
-
Novo Holdings says its acquisition of Catalent is complete. - The Herald-Times
-
Pharmalittle: We're reading about ballooning 340B drug sales, Catalent reassuring customers, and more - STAT
-
EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6 - Yahoo Finance
-
The biotech updates you need to read this morning - STAT
-
Catalent paves the way for Novo’s US GLP-1 expansion - BioProcess Insider
-
Italy Blocks Chinese AI Model DeepSeek Over Data Privacy Concerns - PYMNTS.com
-
Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants - STAT
-
Italy Blocks Chinese AI Model DeepSeek Over Data Privacy Concerns - PYMNTS.com
-
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up - Yahoo Finance
-
Novo Catalent deal clears regulatory hurdles - BioProcess Insider
-
EU approves Novo’s Catalent acquisition, step forward for Bloomington plant workers - Indiana Daily Student
-
Novo completes $16.5bn takeover of Catalent - pharmaphorum
-
Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings - STAT
-
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results - Business Wire
-
Novo Holdings wins EU blessing for Catalent buy - FirstWord Pharma
-
Ardena signs agreement to acquire Catalent manufacturing facility - European Pharmaceutical Manufacturer
-
Novo Holdings Completes Regulatory Hurdles for Catalent Acquisition - Contract Pharma
-
Former FTC director weighs in on Novo's $16.5B deal with Catalent - FiercePharma
-
Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval - Yahoo Finance
-
Novo rides high as Catalent deal nears closure, new site on home turf - FirstWord Pharma
-
US FTC seeks more information on Novo Nordisk parent-Catalent deal - Reuters.com
-
Skadden, Goodwin, Davis Polk act as Novo closes $16.5bn Catalent deal - The Global Legal Post
-
Catalent acquired by Novo Holdings for $16.5 billion - Investing.com
-
Catalent reports Q4 earnings above analyst estimates - Indiana Daily Student
-
Novo Holdings Completes Acquisition of Catalent - citybiz
-
Lennox To Join S&P 500 Index, Replacing Catalent - Investor's Business Daily
-
FTC OKs Novo-Catalent deal in major win for Novo Nordisk’s GLP-1 manufacturing - Endpoints News
-
The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed - Yahoo Finance
-
Italy Blocks Chinese AI Model DeepSeek Over Data Privacy Concerns - PYMNTS.com
-
Ardena Agrees to Acquire Catalent’s Somerset, NJ Facility - Contract Pharma
-
Danish pharma giant cleared to buy Catalent | news - Indiana Public Media
-
Viridian confirms benefit of drug for thyroid eye disease - STAT
-
Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle - MM+M Online
-
Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants? - STAT
-
Italy Blocks Chinese AI Model DeepSeek Over Data Privacy Concerns - PYMNTS.com
-
Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings’ Catalent Buyout - BioSpace
-
Catalent Stock: Analyst Estimates & Ratings - Nasdaq
-
Novo, Catalent $16.5B merger wins EU blessing as US antitrust scrutiny mounts - PharmaLive
-
Catalent stockholders approve buyout by Novo Holdings - Reuters.com
-
Contract Clinical Research Organization Market Set to Witness Significant Growth by 2025-2032:ICON plc, - EIN News
-
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say - Yahoo Finance
-
Novo’s $16.5B Deal with Catalent Gets Another 30 Days Added to FTC Antitrust Review - BioSpace
More catalent websites:
About catalent
Warning: filemtime(): stat failed for aCache/search/dk/catalent in
/var/www/hoodb/function.php on line
339
1738774899-
Back to Top
1738774899-1738564437